Grantia

European Partnership on Personalised Medicine

Funding for collaborative research projects that advance personalised medicine through knowledge exchange, capacity building, and networking between institutions. Targets research teams in EU Member States and associated countries.

Details

Agency

EU Commission

Status

Upcoming

Language

English

Funding Type

Grant

Deadline

2026-02-26

Open Date

2025-12-10

Overview

Funding for collaborative research projects that advance personalised medicine through knowledge exchange, capacity building, and networking between institutions. Targets research teams in EU Member States and associated countries.

Who Can Apply

Consortia of at least three independent legal entities from three different eligible countries, including at least two from EU Member States or associated countries. Eligible applicants include universities, research institutes, hospitals, SMEs, and public bodies.

Funding Details

Total budget: 5 million EUR. Maximum funding per project: 300,000 EUR. Funding rate: 100% of eligible costs for non-profit entities; 70% for for-profit entities. No co-funding required.

What Is Funded

Projects focusing on personalised medicine, including but not limited to:
  • Knowledge transfer and capacity building between institutions
  • Networking and collaboration to strengthen research excellence
  • Development of joint research strategies and methodologies
  • Training and exchange programs for researchers

Technology / Maturity Requirements

No explicit Technology Readiness Level (TRL) requirements. Projects should demonstrate a clear pathway for advancing personalised medicine research and implementation.

Key Dates

  • Open date: 2025-12-09
  • Deadline: 2026-02-25

Application Process (High-Level)

Single-stage application process. Applications must be submitted via the EP PerMed submission portal.

Geographic Scope & Language

Eligible countries: EU Member States and Horizon Europe associated countries. Application language: English.

Notes

Projects must align with the strategic research and innovation agenda of the European Partnership on Personalised Medicine. Consortia are encouraged to include partners from widening countries to promote inclusiveness.